Smoking cessation strategies: An in-depth analysis of nicotine replacement therapy and alternatives
DOI:
https://doi.org/10.12775/JEHS.2023.45.01.024Keywords
NRT, Nicotine Replacement Therapy, Smoking Cessation, Tobacco Addiction, Nicotine DependenceAbstract
Introduction and purpose: The primary objective of this literature review is to thoroughly investigate the topic of nicotine replacement therapy, considering the latest discoveries and detailing various forms of available nicotine substitution.
Materials and methods: Literature review of PubMed and Google Scholar databases.
State of Knowledge: Tobacco smoking remains one of the leading causes of premature death worldwide, accounting for millions of deaths each year. Nicotine, the addictive component of tobacco, is responsible for sustaining cigarette smoking patterns and making smoking cessation particularly challenging. Nicotine replacement therapy (NRT) is now considered one of the primary methods to help individuals quit smoking by reducing withdrawal symptoms and cravings associated with cessation.
Conclusions: Over the years, extensive research has confirmed the effectiveness and safety of NRT, resulting in the development of different forms of nicotine substitution. The outcomes of using these various forms are similar and premature discontinuation by patients remains a primary reason for NRT failure. Therefore, it is crucial for each patient to select the form of NRT that meets their individual preferences. The best results are obtained by combining multiple forms of substitution simultaneously, as well as integrating them with other therapeutic methods.
References
WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Tran TPT, Park J, Nguyen TNP, Hoang VM, Lim MK. Association between perceived harm of tobacco and intention to quit: a cross-sectional analysis of the Vietnam Global Adult Tobacco Survey. BMC Public Health. 2022 May 6;22(1):909. doi: 10.1186/s12889-022-13348-w. PMID: 35524326; PMCID: PMC9077992.
Veeraiah S, Elangovan V, Tripathy JP, Krishnamurthy A, Anand T, Reddy MM, Sudhakar R, K N, Subramani D, Rajaraman S, Elluswami HR, Nirgude A. Quit attempts among tobacco users identified in the Tamil Nadu Tobacco Survey of 2015/2016: a 3 year follow-up mixed methods study. BMJ Open. 2020 Sep 3;10(9):e034607. doi: 10.1136/bmjopen-2019-034607. PMID: 32883722; PMCID: PMC7473619.
Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. 3, Chemistry and Toxicology of Cigarette Smoke and Biomarkers of Exposure and Harm. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53014/
Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71. doi: 10.1146/annurev.pharmtox.48.113006.094742. PMID: 18834313; PMCID: PMC2946180.
Fowler CD, Turner JR, Imad Damaj M. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. Handb Exp Pharmacol. 2020;258:373-393. doi: 10.1007/164_2019_252. PMID: 31267166.
Wittenberg RE, Wolfman SL, De Biasi M, Dani JA. Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. Neuropharmacology. 2020 Oct 15;177:108256. doi: 10.1016/j.neuropharm.2020.108256. Epub 2020 Jul 29. PMID: 32738308; PMCID: PMC7554201.
Schneider NG, Popek P, Jarvik ME, Gritz ER. The use of nicotine gum during cessation of smoking. Am J Psychiatry. 1977 Apr;134(4):439-40. doi: 10.1176/ajp.134.4.439. PMID: 842737.
Puska P, Bjŏrkqvist S, Koskela K. Nicotine-containing chewing gum in smoking cessation: a double blind trial with half year follow-up. Addict Behav. 1979;4(2):141-6. doi: 10.1016/0306-4603(79)90048-0. PMID: 382765.
Shiffman S, Rolf CN, Hellebusch SJ, Gorsline J, Gorodetzky CW, Chiang YK, Schleusener DS, Di Marino ME. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction. 2002 May;97(5):505-16. doi: 10.1046/j.1360-0443.2002.00141.x. PMID: 12033652.
Sumana CK, Nagaraj T, Nigam H, Gogula S, Saxena S. Nicotine replacement therapy: A review. J Med Radiol Pathol Surg. 2018;5:6–8.
Henningfield JE, Radzius A, Cooper TM, Clayton RR. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA. 1990 Sep 26;264(12):1560-4. PMID: 2395197.
Benowitz NL, Jacob P 3rd, Savanapridi C. Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther. 1987 Apr;41(4):467-73. doi: 10.1038/clpt.1987.58. PMID: 3829583.
Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF, Ferguson CL. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl). 2003 Apr;166(4):343-50. doi: 10.1007/s00213-002-1338-1. Epub 2003 Feb 25. PMID: 12601502.
Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;(192):29-60. doi: 10.1007/978-3-540-69248-5_2. PMID: 19184645; PMCID: PMC2953858.
Shiffman S, Cone EJ, Buchhalter AR, Henningfield JE, Rohay JM, Gitchell JG, Pinney JM, Chau T. Rapid absorption of nicotine from new nicotine gum formulations. Pharmacol Biochem Behav. 2009 Jan;91(3):380-4. doi: 10.1016/j.pbb.2008.08.012. Epub 2008 Aug 16. PMID: 18762208.
Niaura R, Sayette M, Shiffman S, Glover ED, Nides M, Shelanski M, Shadel W, Koslo R, Robbins B, Sorrentino J. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction. 2005 Nov;100(11):1720-30. doi: 10.1111/j.1360-0443.2005.01218.x. PMID: 16277632.
Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365. doi: 10.1016/j.jacc.2018.10.027. Epub 2018 Dec 5. PMID: 30527452.
Xiao D, Kotler M, Kang J, Wang C. A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation. J Addict Med. 2020 Jan/Feb;14(1):69-77. doi: 10.1097/ADM.0000000000000547. PMID: 31658113; PMCID: PMC7012347.
Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med. 1995 Nov 2;333(18):1196-203. doi: 10.1056/NEJM199511023331807. PMID: 7565976.
A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000 Jun 28;283(24):3244-54. PMID: 10866874.
Molander L, Lunell E. Pharmacokinetic investigation of a nicotine sublingual tablet. Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):813-9. doi: 10.1007/s002280000223. PMID: 11294371.
Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005 Sep-Oct;55(5):281-99; quiz 322-3, 325. doi: 10.3322/canjclin.55.5.281. PMID: 16166074.
Brokowski L, Chen J, Tanner S. High-dose transdermal nicotine replacement for tobacco cessation. Am J Health Syst Pharm. 2014 Apr 15;71(8):634-8. doi: 10.2146/ajhp130543. PMID: 24688036.
Agarwal A, Reddy LVK, Saha S, Sinha P. Nicotine replacement therapy: An insight. Int J Oral Health Med Res. 2017;4:76–9.
Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008 Aug;35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. PMID: 18617085; PMCID: PMC4465757.
Oncken C, Campbell W, Chan G, Hatsukami D, Kranzler HR. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. J Matern Fetal Neonatal Med. 2009 Sep;22(9):751-8. doi: 10.3109/14767050902994515. PMID: 19526424; PMCID: PMC3169999.
Devi RE, Barman D, Sinha S, Hazarika SJ, Das S. Nicotine replacement therapy: A friend or foe. J Family Med Prim Care. 2020 Jun 30;9(6):2615-2620. doi: 10.4103/jfmpc.jfmpc_313_20. PMID: 32984096; PMCID: PMC7491776.
Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med. 1999 Sep 27;159(17):2033-8. doi: 10.1001/archinte.159.17.2033. PMID: 10510989.
Gupta R, Bharat A, Dhiman U, Sharma A. Nicotine replacement therapy: A smoking cessation aid… An overview. Int J Oral Health Dent. 2019;5:69–75.
Smith LC, George O. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models. Neuropharmacology. 2020 Nov 1;178:108225. doi: 10.1016/j.neuropharm.2020.108225. Epub 2020 Aug 3. PMID: 32758566; PMCID: PMC8344403.
Khan SR, Berendt RT, Ellison CD, Ciavarella AB, Asafu-Adjaye E, Khan MA, Faustino PJ. Bupropion Hydrochloride. Profiles Drug Subst Excip Relat Methodol. 2016;41:1-30. doi: 10.1016/bs.podrm.2015.12.001. Epub 2016 Feb 17. PMID: 26940167.
Choi HK, Ataucuri-Vargas J, Lin C, Singrey A. The current state of tobacco cessation treatment. Cleve Clin J Med. 2021 Jul 1;88(7):393-404. doi: 10.3949/ccjm.88a.20099. PMID: 34210714.
Tashkin DP. Smoking Cessation in Chronic Obstructive Pulmonary Disease. Semin Respir Crit Care Med. 2015 Aug;36(4):491-507. doi: 10.1055/s-0035-1555610. Epub 2015 Aug 3. PMID: 26238637.
García-Gómez L, Hernández-Pérez A, Noé-Díaz V, Riesco-Miranda JA, Jiménez-Ruiz C. SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS. Rev Invest Clin. 2019;71(1):7-16. doi: 10.24875/RIC.18002629. PMID: 30810545.
Vidrine JI, Cofta-Woerpel L, Daza P, Wright KL, Wetter DW. Smoking cessation 2: behavioral treatments. Behav Med. 2006 Fall;32(3):99-109. doi: 10.3200/BMED.32.3.99-109. PMID: 17120385.
Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. PMID: 23728690; PMCID: PMC8406789.
Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Update in: Cochrane Database Syst Rev. 2012;11:CD000146. PMID: 18253970.
Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. PMID: 30997928; PMCID: PMC6470854.
Mendelsohn C. Optimising nicotine replacement therapy in clinical practice. Aust Fam Physician. 2013 May;42(5):305-9. PMID: 23781531.
Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011 Feb;13(2):94-102. doi: 10.1093/ntr/ntq215. Epub 2010 Dec 8. PMID: 21147894; PMCID: PMC3028191.
Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5. PMID: 29852054; PMCID: PMC6353172.
Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010 Jul 13;8(1):8. doi: 10.1186/1617-9625-8-8. PMID: 20626883; PMCID: PMC2917405.
Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs. 2001;15(6):453-67. doi: 10.2165/00023210-200115060-00004. PMID: 11524024.
Lam C, West A. Are electronic nicotine delivery systems an effective smoking cessation tool? Can J Respir Ther. 2015 Fall;51(4):93-8. PMID: 26566380; PMCID: PMC4631136.
McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. PMID: 25515689.
Palazzolo DL. Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front Public Health. 2013 Nov 18;1:56. doi: 10.3389/fpubh.2013.00056. PMID: 24350225; PMCID: PMC3859972.
Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019 Sep 30;366:l5275. doi: 10.1136/bmj.l5275. Erratum in: BMJ. 2019 Oct 15;367:l5980. PMID: 31570493; PMCID: PMC7850161.
Winnicka L, Shenoy MA. EVALI and the Pulmonary Toxicity of Electronic Cigarettes: A Review. J Gen Intern Med. 2020 Jul;35(7):2130-2135. doi: 10.1007/s11606-020-05813-2. Epub 2020 Apr 3. PMID: 32246394; PMCID: PMC7351931.
Navon L, Jones CM, Ghinai I, King BA, Briss PA, Hacker KA, Layden JE. Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019. MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1034-1039. doi: 10.15585/mmwr.mm6845e1. PMID: 31725708; PMCID: PMC6855514.
Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, Yang J, Primack BA, Andrews JA, Miech RA, Spindle TR, Dick DM, Eissenberg T, Hornik RC, Dang R, Sargent JD. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017 Aug 1;171(8):788-797. doi: 10.1001/jamapediatrics.2017.1488. Erratum in: JAMA Pediatr. 2018 Jan 1;172(1):92-93. Erratum in: JAMA Pediatr. 2018 Jan 1;172(1):98. Erratum in: JAMA Pediatr. 2020 May 1;174(5):509. PMID: 28654986; PMCID: PMC5656237.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Łukasz Mrozek, Aleksandra Hajduk, Krzysztof Puchalski, Maciej Zwolski, Zuzanna Szumlas, Konrad Klocek, Bartosz Kostecki, Aleksander Jurek, Artur Nowak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 278
Number of citations: 0